HC Wainwright Reaffirms Neutral Rating for PMI (NYSEAMERICAN:PMI)

PMI (NYSEAMERICAN:PMIGet Free Report)‘s stock had its “neutral” rating restated by equities researchers at HC Wainwright in a note issued to investors on Wednesday,Benzinga reports.

Separately, Zacks Research upgraded PMI to a “hold” rating in a research note on Tuesday, May 19th. Two research analysts have rated the stock with a Hold rating, According to MarketBeat, the stock has an average rating of “Hold”.

View Our Latest Report on PMI

PMI Stock Up 60.3%

Shares of PMI stock opened at $0.27 on Wednesday. The business has a 50-day moving average price of $0.61. PMI has a 52-week low of $0.11 and a 52-week high of $13.68. The company has a debt-to-equity ratio of 0.01, a current ratio of 0.75 and a quick ratio of 0.16.

PMI (NYSEAMERICAN:PMIGet Free Report) last announced its quarterly earnings results on Friday, May 15th. The company reported ($0.10) earnings per share for the quarter. The company had revenue of $1.15 million for the quarter. As a group, analysts anticipate that PMI will post -0.17 earnings per share for the current fiscal year.

About PMI

(Get Free Report)

Picard Medical Inc is a medical technology company which manufactures and sells the only total artificial heart. Picard Medical Inc is based in TUCSON, Ariz.

Further Reading

Receive News & Ratings for PMI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PMI and related companies with MarketBeat.com's FREE daily email newsletter.